Thiamylal

Thiamylal
Systematic (IUPAC) name
5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
Identifiers
CAS number	77-27-0
ATCvet code	QN01AF90
PubChem	3032285
Chemical data
Formula	C12H18N2O2S
Mol. mass	254.35 g/mol
Synonyms	Thiamylal, Thioseconal, Surital
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status	Schedule III(CA) Schedule III(US)
Routes	?

Thiamylal (Surital) is a barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is used as a strong but short acting sedative. Thamylal is still in current use, primarily for induction in surgical anaesthesia ^[1] or as an anticonvulsant to counteract side effects from other anaesthetics. ^[2] It is the Thiobarbiturate anologue of secobarbital.

References

1. ^ Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300.
2. ^ Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e